SEARCH

SEARCH BY CITATION

REFERENCES

  • 1
    Llovet JM, Burroughs AK, Bruix J. Hepatocellular carcinoma. Lancet 2003; 362: 19071901.
  • 2
    Parkin DM, Bray F, Ferlay J, Pisani P. Estimating the world cancer burden: Globocan 2000. Int J Cancer 2001; 94: 153156.
  • 3
    El Serag HB, Mason AC. Rising incidence of hepatocellular carcinoma in the United States. N Engl J Med 1999; 340: 745750.
  • 4
    Deuffic S, Poynard T, Buffat L, Valleron AJ. Trends in primary liver cancer. Lancet 1998; 11; 351(9097): 214215.
  • 5
    Fattovich G, Giustina G, Degos F, Tremolada F, Diodati G, Almasio P, et al. Morbidity and mortality in a compensated cirrhosis type C: a retrospective follow-up study of 384 patients. Gastroenterology 1997; 112: 463472.
  • 6
    Bruix J, Sherman M, Llovet JM, Beaugrand M, Lencioni R, Burroughs AK, et al, EASL Panel of Experts on HCC. Clinical management of hepatocellular carcinoma. Conclusion of the Barcelona-2000 EASL Conference. J Hepatol 2001; 35: 421430.
  • 7
    Adam R, Del Gaudio M. Evolution of liver transplantation for hepatocellular carcinoma. J Hepatol 2003; 39: 888895.
  • 8
    Burroughs AK, Hochhauser D, Meyer T. Hepatocellular carcinoma: systemic therapy and liver transplantation two ends of the spectrum, Lancet Oncology 2004; 5: 409418.
  • 9
    Sangiovanni A, Del Ninno E, Fasani P, De Fazio C, Ronchi G, Romeo R, et al. Increased survival of cirrhotic patients with a hepatocellular carcinoma detected during surveillance. Gastroenterology 2004; 126: 10051014.
  • 10
    Yuen MF, Cheng CC, Lauder IJ, Lam SK, Doi CG, Lai CL. Early detection of hepatocellular carcinoma increases the chance of treatment: Hong Kong experience. Hepatology 2000; 31: 330335.
  • 11
    Sarasin FP, Giostra E, Hadengue A. Cost-effectiveness of screening for detection of small hepatocellular carcinoma in western patients with Child-Pugh class cirrhosis. Am J Med 1996; 101: 422434.
  • 12
    Arguedas MR, Chen VK, Eloubeidi MA, Fallon MB. Screening for hepatocellular carcinoma in patients with hepatitis C cirrhosis: a cost-utility analysis. Am J Gastroenterol 2003; 98: 679690.
    Direct Link:
  • 13
    Zhang BH, Yang BH, Tang ZY. Randomized controlled trial of screening for hepatocellular carcinoma. J Cancer Res Clin Oncol 2004; 130: 417422.
  • 14
    Bruix J, Sherman M, Practice Guidelines Committee, American Association for the Study of Liver Diseases. Management of hepatocellular carcinoma. Hepatology 2005; 42: 12081236.
  • 15
    Ebara M, Okabe S, Kita K, Sugiura N, Fukuda H, Yoshikawa M, et al. Percutaneous ethanol injection for small hepatocellular carcinoma: therapeutic efficacy based on 20-year observation. J Hepatol 2005; 43: 377380.
  • 16
    Yoshino M. Growth kinetics of hepatocellular carcinoma. Jpn J Clin Oncol 1983; 13: 4552.
  • 17
    Lencioni R, Cioni O, Crocetti L, Della Pina C, Bartolozzi C. Magnetic resonance imaging of liver tumors. J Hepatol 2004; 40: 162171.
  • 18
    Park YN, Yang CP, Fernandez GJ, Cubukcu O, Thung SN, Theise NO. Neoangiogenesis and sinusoidal capillarization in dysplastic nodules of the liver. Am J Surg Pathol 1998; 22: 656662.
  • 19
    Roncalli M, Roz E, Coggi G, Di Rocco MG, Bossi P, Minola E, et al. The vascular profile of regenerative and dysplastic nodules of the liver: implication for diagnosis and classification. Hepatology 1999; 30: 11741178.
  • 20
    Tajima T, Honda H, Taguchi K, Asayama Y, Kuroiwa T, Yoshimitsu K, et al. Sequential haemodynamic change in hepatocellular carcinoma and dysplastic nodules: CT angiography and pathological correlation. AJR Am J Roentgenol 2002; 178: 885897.
  • 21
    Lim JH, Kim CK, Lee WJ, Park CK, Koh KC, Paik SW, et al. Detection of hepatocellular carcinomas and dysplastic nodules in cirrhotic livers: accuracy of helical CT in transplant patients. AJR Am J Roentgenol 2000; 175: 693698.
  • 22
    Nino-Murcia M, Olcott EW, Jeffrey RB Jr, Lamm RL, Beaulieu CF, Jain KA. Focal liver lesions: pattern-based classification scheme for enhancement at arterial phase CT. Radiology 2000; 215: 746751.
  • 23
    Torzilli G, Minagawa M, Takayama T, Inoue K, Hui AM, Kubota K, et al. Accurate preoperative evaluation of liver mass lesions without fine-needle biopsy. Hepatology 1999; 30: 889893.
  • 24
    Levy I, Greig PO, Gallinger S, Langer B, Sherman M. Resection of hepatocellular carcinoma without preoperative tumour biopsy. Ann Surg 2001; 234: 206209.
  • 25
    Stigliano R, Burroughs AK. Should we biopsy each liver mass suspicious for HCC before liver transplantation?—No, please don't. J Hepatol 2005; 43: 563568.
  • 26
    Shuto T, Yamamoto T, Tanaka S, Kanazawa A, Takemura S, Tanaka H, et al. Resection of needle-tract implantation after percutaneous puncture for hepatocellular carcinoma. J Gastroenterol 2004; 39: 907908.
  • 27
    Fung KT, Li FT, Raimondo ML, Maudgil D, Mancuso A, Tibballs JM, et al. Systematic review of radiological imaging for hepatocellular carcinoma in cirrhotic patients. Br J Radiol 2004; 77(920): 633640.
  • 28
    Bruix J, Sherman M, Practice Guidelines Committee, American Association for the Study of Liver Diseases. Management of hepatocellular carcinoma. Hepatology 2005; 42: 12081236.
  • 29
    Trevisani F, D'Intino PE, Morselli-Labate AM, Mazzella G, Accogli E, Caraceni P, et al. Serum alpha-fetoprotein for diagnosis of hepatocellular carcinoma in patients with chronic liver disease: influence of HBsAg and anti-HCV status. J Hepatol 2001; 34: 570575.
  • 30
    Izuno K, Fujiyama S, Yamasaki K, Sato M, Sato T. Early detection of hepatocellular carcinoma associated with cirrhosis by combined assay of des-gamma-carboxy prothrombin and alpha-fetoprotein: a prospective study. Hepatogastroenterology 1995; 42: 387393.
  • 31
    Shah S, Tan J, McGilvray I, et al. Accuracy of staging as a predictor for recurrence after liver transplantation for hepatocellular carcinoma. Transplantation 2006; 81: 16331639.
  • 32
    Gambarin-Gelwan M, Wolf DC, Shapiro R, Schwartz ME, Min AD, et al. Sensitivity of commonly available screening tests in detecting hepatocelluar carcinoma in cirrhotic patients undergoing liver transplantation. Am J Gastroenterol 2000; 95: 15351538.
    Direct Link:
  • 33
    Kim CK, Lim JH, Lee WJ. Detection of hepatocellular carcinoma and dysplastic nodules in cirrhotic liver: accuracy of ultrasonography in transplant patients. J Ultrasound Med 2001; 20: 99104.
  • 34
    Teefey SA, Hildeboldt CC, Dehdashti F, Siegel BA, Peters MG, Heiken JP, et al. Detection of primary hepatic malignancy in liver transplant candidates: prospective comparison of CT, MR imaging, US and PET. Radiology 2003; 226: 533542.
  • 35
    Rode A, Bancel B, Douek P, Chevallier M, Vilgrain V, Picaud G, et al. Small nodule detection in cirrhotic livers: evaluation with US, spiral CT, and MRI and correlation with pathologic examination of explanted liver. J Comput Assist Tomogr 2001; 25: 327336.
  • 36
    Peterson MS, Baron RL. Radiological diagnosis of hepatocellular carcinoma. Clin Liver Dis 2001; 5: 123144.
  • 37
    Lencioni R, Pinto F, Armillotta N, Bartolozzi C. Assessment of tumor vascularity in hepatocellular carcinoma: comparison of power-Doppler US and color-Doppler US. Radiology 1996; 201: 353358.
  • 38
    Lincioni R, Cioni O, Crocetti L, Donati F, Franchini C, Giusti S, et al. Ultrasound imaging of focal liver lesion with a second generation contrast agent. Acad Radiol 2002; 9(Suppl 2): S371S374.
  • 39
    Wen YL, Kudo M, Lheng RQ, Ding H, Lhou P, Minami Y, et al. Characterization of hepatic tumors: value of contrast enhanced coded phase-inversion harmonic angio. AJR Am J Roentgenol 2004; 182: 10191026.
  • 40
    Strobel D, Kleinecke C, Hansler J, Frieser M, Handl T, Hahn EG, et al. Contrast-enhanced sonography for the characterisation of hepatocellular carcinomas—correlation with histological differentiation. Ultraschall Med 2005; 26: 270276.
  • 41
    Giorgio A, Ferraioli G, Tarantino L, de Stefano G, Scala V, Scarano F, et al. Contrast-enhanced sonographic appearance of hepatocellular carcinoma in patients with cirrhosis: comparison with contrast-enhanced helical CT appearance. Am J Roentgenol 2005; 185: 10791080.
  • 42
    Albrecht T, Blomley M, Bolondi L, Claudon M, Correas JM, Cosgrove O, et al, EFSUMB Study Group. Guidelines for the use of contrast agents in ultrasounds. Ultrasound Med 2004; 25: 249.
  • 43
    Gaiani S, Celli N, Piscaglia F, Cecilioni L, Losinno F, Giangregorio F, et al. Usefulness of contrast enhanced computed sonography in the assessment of hepatocellular carcinoma hypervascular at spiral computed tomography. J Hepatol 2004; 41: 421426.
  • 44
    Laghi A, Lannaccone R, Rossi P, Carbone I, Ferrari R, Mangiapane F, et al. Hepatocellular carcinoma: detection with triple-phase multidetector row helical CT in patients with chronic hepatitis. Radiology 2003; 226: 543549.
  • 45
    Francis IR, Cohan RH, McNulty NJ, Platt JF, Korobkin M, Gebremariam A, et al. Multidetector CT of the liver and hepatic neoplasm: effect of multiphasic imaging on tumour conspicuity and vascular enhancement. AJR Am J Roentgenol 2003; 180: 12171224.
  • 46
    Murakami T, Kim T, Kawata S, Kanematsu M, Federle MP, Hori M, et al. Evaluation of optimal timing of arterial phase imaging for the detection of hypervascular hepatocellular carcinoma by using triple arterial phase imaging with multidetector-row helical computed tomography. Invest Radiol 2003; 38: 497453.
  • 47
    Burrel M, Llovet JM, Ayuso C, Iglesias C, Sala M, Miquel R, et al, Barcelona Clinic Liver Cancer Group. MRI angiography is superior to helical CT for detection of HCC prior to liver transplantation: an explant correlation. Hepatology 2003; 38: 10341042.
  • 48
    Valls C, Cos M, Figueras J, Andia E, Ramos E, Sanchez A, et al. Pretransplantation diagnosis and staging of hepatocellular carcinoma in patients with cirrhosis: value of dual phase helical CT. AJR Am J Roentgenol 2004; 182: 10111017.
  • 49
    Oliver JH, Baron LL, Carr BE. CT imaging of hepatocellular carcinoma: CT arteriography versus triphasic helical contrast CT. Radiology 1997; 205(P): 144 A.
  • 50
    Nakayama A, Imamura H, Matsuyama Y, Kitamura H, Miwa S, Kobayashi A, et al. Value of lipiodol computed tomography and digital subtraction angiography in the era of helical biphasic computed tomography as preoperative assessment of hepatocellular carcinoma. Ann Surg 2001; 234: 5662.
  • 51
    Ito K, Fujita T, Shimizu A, Koike S, Sasaki K, Matsunaga N, et al. Multiarterial phase dynamic MRI of small early enhancing hepatic lesions in cirrhosis or chronic hepatitis: differentiating between hypervascular hepatocellular carcinomas and pseudo-lesions. AJR Am J Roentgenol 2004; 183: 699705.
  • 52
    Ward J, Robinson PJ. How to detect hepatocellular carcinoma in cirrhosis. Eur Radiol 2002; 12: 22582272.
  • 53
    Halavaara J, Tervahartiala P, Isoniemi H, Hockerstedt K. Efficacy of sequential use of superparamagnetic iron oxide and gadolinium in liver MR imaging. Acta Radiol 2002; 43: 180185.
  • 54
    Krinsky GA, Lee VS, Theise NO, Weinreb JC, Rofsky NM, Diflo T, et al. Hepatocellular carcinomas and dysplastic nodules in patients with cirrhosis: prospective diagnosis with MR imaging and explanation correlation. Radiology 2001; 219: 445454.
  • 55
    Bhartia B, Ward J, Guthrie JA, Robinson PJ. Hepatocellular carcinoma in cirrhotic livers: double-contrast thin section–MR imaging with pathologic correlation of explanted tissue. Am J Roentgenol 2003; 180: 577584.
  • 56
    Marelli L, Grasso A, Stigliano R, Morisco F, Martines H, Dhillon AP, et al. The size of largest nodule—not the number of nodules—is the best predictor of recurrence of hepatocellular carcinoma after liver transplantation. J Hepatol 2007; 46(suppl 1): S108.
  • 57
    International Working Party. Terminology of nodular hepatocellular lesions. Hepatology 1995; 22: 983989.
  • 58
    Borzio M, Fargion S, Borzio F, Fracanzani AL, Croce AM, Stroffolini T, et al. Impact of large regenerative, low grade and high grade dysplastic nodules in hepatocellular carcinoma development. J Hepatol 2003; 39: 209214.
  • 59
    Stigliano R, Marelli L, Yu D, Davies N, Pach D, Burroughs AK. Seeding following percutaneous and therapeutic approaches for hepatocellular carcinoma. What is the risk and outcome? Seeding risk for percutaneous approach of HCC. Cancer Rev 2007; 33: 437447.
  • 60
    Bolondi L, Gaiani S, Celli N, Golfieri R, Grigioni WF, Leoni S, et al. Characterization of small nodules in cirrhosis by assessment of vascularity: the problem of hypovascular hepatocellular carcinoma. Hepatology 2005; 142: 2734.
  • 61
    Sharma P, Balan V, Hernandez JL, Harper AM, Edwards EB, Rodriguez-Luna H, et al. Liver transplantation for hepatocellular carcinoma: the MELD impact. Liver Transpl 2004; 10: 3641.
  • 62
    Wiesner RH, Freeman RB, Mulligan DC. Liver transplantation for hepatocellular cancer: the impact of the MELD allocation policy. Gastroenterology 2004; 127(5 Suppl 1 ): S261S267.
  • 63
    Freeman RB, Mithoerfer A, Ruthazer R, Nguyen K, Schore A, Harper A, et al. Optimizing staging for hepatocellular carcinoma before liver transplantation: a retrospective analysis of the UNOS/OPTN database. Liver Transpl 2006; 12: 15041511.
  • 64
    Llovet JM, Chen Y, Wurmbach E, Roayaie S, Fiel MI, Schwartz M, et al. A molecular signature to discriminate dysplastic nodules from early hepatocelluar carcinoma in HCV cirrhosis. Gastroenterology 2006; 131: 17581767.
  • 65
    Herrero JL, Sangro, B, Quiroga J, Pardo F, Herraiz M, Cienfuegos JA. Influence of tumor characteristics on the outcome of liver transplantation in patients with cirrhosis and hepatocellular carcinoma. Liver Transplant 2001; 7: 631636.
  • 66
    Roayaie S, Frischer JS, Emre SH, Fishbein TM, Sheiner PA, Sung M, et al. Long-term results with multimodal adjuvant therapy and liver transplantation for the treatment of HCC longer than 5 centimetres. Ann Surg 2002; 235: 533539.
  • 67
    Marsh JW, Dvorchik I. liver organ allocation for HCC: are we sure? Liver Transpl 2003; 9: 693696.
  • 68
    Kneteman NM, Oberholzer J, Al Saghier M, Meeberg GA, Blitz M, Ma MM, et al. Sirolimus-based immunosuppression for liver transplantation in the presence of extended criteria for hepatocellular carcinoma. Hepatology 2001; 33: 13941403.
  • 69
    Yao FY, Ferrell L, Bass NM, Watson JJ, Bacchetti P, Venook A, et al. Liver transplantation for hepatocellular carcinoma: expansion of the tumor size limits does not adversely impact survival hepatology. Hepatology 2001; 33: 13941403.
  • 70
    Llovet JM, Schwartz M, Mazzaferro V. Resection and liver transplantation for hepatocellular carcinoma. Semin Liver Dis 2005; 25: 181200.
  • 71
    Leung JY, Zhu AX, Gordon FD, Pratt DS, Mithoefer A, Garrigan K, et al. Liver transplantation outcomes for early-stage hepatocellular carcinoma: results of a multicenter study liver transplant 2004;10: 13431354.
  • 72
    Schwartz M. Liver transplantation for hepatocelluar carcinoma. Gastroenterology 2004; 127(Suppl 1): S268S276.
  • 73
    Hwang S, Lee SG, Joh JW, Suh KS, Kim DG. Liver transplantation for adult patients with hepatocellular carcinoma in Korea: comparison between cadaveric donor and living donor liver transplantations Liver Transpl 2005; 11: 12651272.
  • 74
    Decaens T, Roudot-Thoraval F, Hadni-Bresson S, Meyer C, Gugenheim J, Durand F, et al. Impact of UCSF criteria according to pre- and post-OLT tumor features: analysis of 479 patients listed for HCC with a short-waiting time. Liver Transpl 2006; 12: 17619.